Lexington drug company goes for $8.4 billion

Associated Press reports Merck is buying Cubist Technology, which specializes in trying to come up with drugs that will battle bacteria resistant to existing antibiotics - a growing problem that could return us to the days when simple cuts or injuries could result in deadly infections.